These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 21165759)
1. Quantitative structure-activity relationship analysis of β-amyloid aggregation inhibitors. Stempler S; Levy-Sakin M; Frydman-Marom A; Amir Y; Scherzer-Attali R; Buzhansky L; Gazit E; Senderowitz H J Comput Aided Mol Des; 2011 Feb; 25(2):135-44. PubMed ID: 21165759 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of amyloid-β aggregation in Alzheimer's disease. Wang Q; Yu X; Li L; Zheng J Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775 [TBL] [Abstract][Full Text] [Related]
3. Molecular docking, molecular dynamics simulations and QSAR studies on some of 2-arylethenylquinoline derivatives for inhibition of Alzheimer's amyloid-beta aggregation: Insight into mechanism of interactions and parameters for design of new inhibitors. Safarizadeh H; Garkani-Nejad Z J Mol Graph Model; 2019 Mar; 87():129-143. PubMed ID: 30537643 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of β-hairpin mimics as modulators of amyloid β-peptide aggregation. Tonali N; Kaffy J; Soulier JL; Gelmi ML; Erba E; Taverna M; van Heijenoort C; Ha-Duong T; Ongeri S Eur J Med Chem; 2018 Jun; 154():280-293. PubMed ID: 29807333 [TBL] [Abstract][Full Text] [Related]
5. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β Shuaib S; Goyal B J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045 [TBL] [Abstract][Full Text] [Related]
6. Beta-amyloid aggregation inhibitors for the treatment of Alzheimer's disease: dream or reality? Talaga P Mini Rev Med Chem; 2001 Jul; 1(2):175-86. PubMed ID: 12369982 [TBL] [Abstract][Full Text] [Related]
7. Computational design and evaluation of β-sheet breaker peptides for destabilizing Alzheimer's amyloid-β Shuaib S; Narang SS; Goyal D; Goyal B J Cell Biochem; 2019 Oct; 120(10):17935-17950. PubMed ID: 31162715 [TBL] [Abstract][Full Text] [Related]
8. Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design. Mishra P; Ayyannan SR; Panda G ChemMedChem; 2015 Sep; 10(9):1467-74. PubMed ID: 26230674 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of 2,6-disubstituted pyridine derivatives as inhibitors of β-amyloid-42 aggregation. Kroth H; Sreenivasachary N; Hamel A; Benderitter P; Varisco Y; Giriens V; Paganetti P; Froestl W; Pfeifer A; Muhs A Bioorg Med Chem Lett; 2016 Jul; 26(14):3330-3335. PubMed ID: 27256911 [TBL] [Abstract][Full Text] [Related]
10. Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates. Viayna E; Sabate R; Muñoz-Torrero D Curr Top Med Chem; 2013; 13(15):1820-42. PubMed ID: 23931440 [TBL] [Abstract][Full Text] [Related]
11. Rational design and identification of a non-peptidic aggregation inhibitor of amyloid-β based on a pharmacophore motif obtained from cyclo[-Lys-Leu-Val-Phe-Phe-]. Arai T; Araya T; Sasaki D; Taniguchi A; Sato T; Sohma Y; Kanai M Angew Chem Int Ed Engl; 2014 Jul; 53(31):8236-9. PubMed ID: 24931598 [TBL] [Abstract][Full Text] [Related]
12. Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules. Marondedze EF; Govender KK; Govender PP J Mol Graph Model; 2020 Dec; 101():107711. PubMed ID: 32898834 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease. Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ Asadbegi M; Shamloo A ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950 [TBL] [Abstract][Full Text] [Related]
15. Strategic Design of 2,2'-Bipyridine Derivatives to Modulate Metal-Amyloid-β Aggregation. Ji Y; Lee HJ; Kim M; Nam G; Lee SJC; Cho J; Park CM; Lim MH Inorg Chem; 2017 Jun; 56(11):6695-6705. PubMed ID: 28485587 [TBL] [Abstract][Full Text] [Related]
16. Structures of Aβ17-42 trimers in isolation and with five small-molecule drugs using a hierarchical computational procedure. Chebaro Y; Jiang P; Zang T; Mu Y; Nguyen PH; Mousseau N; Derreumaux P J Phys Chem B; 2012 Jul; 116(29):8412-22. PubMed ID: 22283547 [TBL] [Abstract][Full Text] [Related]
17. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis. Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517 [TBL] [Abstract][Full Text] [Related]
18. Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease. Goyal D; Shuaib S; Mann S; Goyal B ACS Comb Sci; 2017 Feb; 19(2):55-80. PubMed ID: 28045249 [TBL] [Abstract][Full Text] [Related]
19. Disrupting beta-amyloid aggregation for Alzheimer disease treatment. Estrada LD; Soto C Curr Top Med Chem; 2007; 7(1):115-26. PubMed ID: 17266599 [TBL] [Abstract][Full Text] [Related]
20. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease. Savelieff MG; DeToma AS; Derrick JS; Lim MH Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]